Signaling Pathways - Histone Deacetylases (HDACs) - P110 - MK2 - Cancer
清除全部
- B4890 HPOB1 CitationTarget: Histone Deacetylases (HDACs)Summary: HDAC6抑制剂
- B4856 CAY10603Target: Histone Deacetylases (HDACs)Summary: HDAC6抑制剂
- B4794 Santacruzamate A (CAY10683)Target: Histone Deacetylases (HDACs)Summary: HDAC抑制剂
- B6962 CMPD-1Target: Microtubules/Tubulins|MK2Summary: p38α介导的MK2a磷酸化的抑制剂
- B2172 PP121Target: mTOR|Eph Receptors|VEGFR|PDGFR|Bcr-Abl|Src|DNA-PK|P110|HckSummary: 酪氨酸激酶和磷酸肌醇激酶双重抑制剂
- A8803 RGFP9664 CitationTarget: Histone Deacetylases (HDACs)Summary: HDAC3抑制剂
- A8547 Tubastatin A HCl1 CitationTarget: Histone Deacetylases (HDACs)Summary: HDAC6(组蛋白去乙酰化酶6)抑制剂
- A4500 TCS HDAC6 20b1 CitationTarget: Histone Deacetylases (HDACs)Summary: HDAC6的选择性抑制剂
- A4496 NSC 3852Target: Histone Deacetylases (HDACs)Summary: HDAC抑制剂
- A3721 PHA-767491Target: Cyclin-Dependent Kinases|MK2|Cdc7Summary: Cdc7 / CDK9抑制剂